Prostate-specific membrane antigen (PSMA)-targeted photodynamic therapy enhances the delivery of PSMA-targeted magnetic nanoparticles to PSMA-expressing prostate tumors
Year: 2021
Type: article
Abstract: Enhanced vascular permeability in tumors plays an essential role in nanoparticle delivery.Prostate-specific membrane antigen (PSMA) is overexpressed on the epithelium of aggressive prostate cancers (PCs).Here, we evaluated the feasibility of increasing the delivery of PSMA-targeted magnetic nanoparticles (MNPs) to tumors by enhancing vascular permeability in PSMA(+) PC tumors with PSMA-targeted photodynamic therapy (PDT).Method: PSMA(+) PC3 PIP tumor-bearing mice were given a low-molecular-weight PSMA-targeted photosensitizer and treated with fluorescence image-guided PDT, 4 h after.The mice were then given a PSMA-targeted MNP immediately after PDT and monitored with fluorescence imaging and T2-weighted magnetic resonance imaging (T2-W MRI) 18 h, 42 h, and 66 h after MNP administration.Untreated PSMA(+) PC3 PIP tumor-bearing mice were used as negative controls.Results: An 8-fold increase in the delivery of the PSMA-targeted MNPs was detected using T2-W MRI in the pretreated tumors 42 h after PDT, compared to untreated tumors.Additionally, T2-W MRIs revealed enhanced peripheral intra-tumoral delivery of the PSMA-targeted MNPs.That finding is in keeping with two-photon microscopy, which revealed higher vascular densities at the tumor periphery.Conclusion: These results suggest that PSMA-targeted PDT enhances the delivery of PSMA-targeted MNPs to PSMA(+) tumors by enhancing the vascular permeability of the tumors.
Source: Nanotheranostics
DOI: 10.7150/ntno.52361
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $668
Awards: PSMA Directed Imaging of Prostate Cancer Focus on Androgen Receptor Dynamics, JHU ICMIC Program, SPORE in Prostate Cancer, MRI biosensors and complementary drug nanocarriers for effective image-guided drug delivery and early tumor response assessment of pediatric medulloblastomas, Enhanced imaging and treatment of aggressive subtypes of prostate cancer, Resource for Molecular Imaging Agents in Precision Medicine
OpenAlex ID: W3128027682
